The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

The World Health Organization (WHO) and UNICEF have raised the alarm over widening immunization gaps globally, warning that millions of ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

The World Health Organization (WHO) has recommended the global use of injectable lenacapavir (LEN) twice a year to provide near-total ...

As Professor of Infectious Diseases and Microbiology Paul Griffin explains in a recent piece for The Conversation, Stratus is ...

The World Health Organization (WHO) has released a new policy brief entitled " Tuberculosis and primary health care: synergies and opportunities ...

Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative to daily pills and addressing the needs of key populations.

The facility is fully accredited by the World Health Organization (WHO) and recognized as one of the most advanced polio ...

A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...